Suppr超能文献

肝硬化腹水患者肠道大分子通透性增加及尿亚硝酸盐排泄增加。

Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites.

作者信息

Lee Soong, Son Seung-Cheol, Han Moon-Jong, Kim Woo-Jin, Kim Soo-Hyun, Kim Hye-Ran, Jeon Woo-Kyu, Park Ki-Hong, Shin Myung-Geun

机构信息

Department of Laboratory Medicine, Chonnam National University Medical School and Chonnam National University Hwasun Hospital, Hwasun, Korea.

出版信息

World J Gastroenterol. 2008 Jun 28;14(24):3884-90. doi: 10.3748/wjg.14.3884.

Abstract

AIM

To determine intestinal permeability, the serum tumor necrosis factor (TNF)-alpha level and urine nitric oxide (NO) metabolites are altered in liver cirrhosis (LC) with or without ascites.

METHODS

Fifty-three patients with LC and 26 healthy control subjects were enrolled in the study. The intestinal permeability value is expressed as the percentage of polyethylene glycol (PEG) 400 and 3350 retrieval in 8-h urine samples as determined by high performance liquid chromatography. Serum TNF-alpha concentrations and urine NO metabolites were determined using an enzyme-linked immunosorbent assay (ELISA) and Greiss reaction method, respectively.

RESULTS

The intestinal permeability index was significantly higher in patients with LC with ascites than in healthy control subjects or patients with LC without ascites (0.88 +/- 0.12 vs 0.52 +/- 0.05 or 0.53 +/- 0.03, P < 0.05) and correlated with urine nitrite excretion (r = 0.98). Interestingly, the serum TNF-alpha concentration was significantly higher in LC without ascites than in control subjects or in LC with ascites (198.9 +/- 55.8 pg/mL vs 40.9 +/- 12.3 pg/mL or 32.1 +/- 13.3 pg/mL, P < 0.05). Urine nitrite excretion was significantly higher in LC with ascites than in the control subjects or in LC without ascites (1170.9 +/- 28.7 micromol/L vs 903.1 +/- 55.1 micromol/L or 956.7 +/- 47.7 micromol/L, P < 0.05).

CONCLUSION

Increased intestinal macromolecular permeability and NO is probably of importance in the pathophysiology and progression of LC with ascites, but the serum TNF-alpha concentration was not related to LC with ascites.

摘要

目的

确定伴有或不伴有腹水的肝硬化(LC)患者的肠道通透性、血清肿瘤坏死因子(TNF)-α水平及尿一氧化氮(NO)代谢产物是否发生改变。

方法

本研究纳入了53例LC患者和26例健康对照者。肠道通透性值通过高效液相色谱法测定8小时尿液样本中聚乙二醇(PEG)400和3350的回收率来表示。血清TNF-α浓度和尿NO代谢产物分别采用酶联免疫吸附测定(ELISA)和格里斯反应法进行测定。

结果

伴有腹水的LC患者的肠道通透性指数显著高于健康对照者或不伴有腹水的LC患者(0.88±0.12 vs 0.52±0.05或0.53±0.03,P<0.05),且与尿亚硝酸盐排泄相关(r = 0.98)。有趣的是,不伴有腹水的LC患者的血清TNF-α浓度显著高于对照者或伴有腹水的LC患者(198.9±55.8 pg/mL vs 40.9±12.3 pg/mL或32.1±13.3 pg/mL,P<0.05)。伴有腹水的LC患者的尿亚硝酸盐排泄显著高于对照者或不伴有腹水的LC患者(1170.9±28.7 μmol/L vs �03.1±55.1 μmol/L或956.7±47.7 μmol/L,P<0.05)。

结论

肠道大分子通透性增加和NO可能在伴有腹水的LC的病理生理学和进展中起重要作用,但血清TNF-α浓度与伴有腹水的LC无关。

相似文献

3
Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?
Am J Gastroenterol. 2010 Feb;105(2):323-7. doi: 10.1038/ajg.2009.558. Epub 2009 Oct 20.
5
Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study.
Eur J Gastroenterol Hepatol. 2010 Oct;22(10):1228-34. doi: 10.1097/MEG.0b013e32833b4b03.
6
Intestinal permeability in cirrhotic patients with and without ascites.
Scand J Gastroenterol. 2006 Mar;41(3):326-30. doi: 10.1080/00365520510024278.
7
Intestinal barrier dysfunction in liver cirrhosis assessed by iohexol test.
Eur Rev Med Pharmacol Sci. 2020 Jan;24(1):315-322. doi: 10.26355/eurrev_202001_19928.
10

引用本文的文献

1
Gut Microbial Dysbiosis and Implications in Solid Organ Transplantation.
Biomedicines. 2024 Dec 9;12(12):2792. doi: 10.3390/biomedicines12122792.
4
Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update.
Gut Liver. 2021 Sep 15;15(5):666-676. doi: 10.5009/gnl20032.
5
Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis.
Biomed Res Int. 2020 Jul 6;2020:3743962. doi: 10.1155/2020/3743962. eCollection 2020.
6
Oral Phosphatidylcholine Improves Intestinal Barrier Function in Drug-Induced Liver Injury in Rats.
Gastroenterol Res Pract. 2019 Sep 2;2019:8723460. doi: 10.1155/2019/8723460. eCollection 2019.
7
Quantitative Measure of Intestinal Permeability Using Blue Food Coloring.
J Surg Res. 2019 Jan;233:20-25. doi: 10.1016/j.jss.2018.07.005. Epub 2018 Jul 27.
8
Changes of Intestinal Functions in Liver Cirrhosis.
Inflamm Intest Dis. 2016 Apr;1(1):24-40. doi: 10.1159/000444436. Epub 2016 Mar 8.
9
Intestinal permeability in a patient with liver cirrhosis.
Ther Clin Risk Manag. 2016 Nov 18;12:1729-1748. doi: 10.2147/TCRM.S115902. eCollection 2016.

本文引用的文献

1
Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients.
World J Gastroenterol. 2007 Jan 21;13(3):421-5. doi: 10.3748/wjg.v13.i3.421.
3
Intestinal permeability in cirrhotic patients with and without ascites.
Scand J Gastroenterol. 2006 Mar;41(3):326-30. doi: 10.1080/00365520510024278.
4
Implication of inflammation-related cytokines in the natural history of liver cirrhosis.
Liver Int. 2004 Oct;24(5):437-45. doi: 10.1111/j.1478-3231.2004.0951.x.
6
Analysis of PEG 400 and 4000 in urine for gut permeability assessment using solid phase extraction and gel permeation chromatography with refractometric detection.
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jun 15;805(2):195-202. doi: 10.1016/j.jchromb.2004.02.033.
10
Intestinal permeability is increased in patients with advanced cirrhosis.
Hepatogastroenterology. 2003 Sep-Oct;50(53):1482-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验